Johnson Chemical Pharmaceutical Works Co (ROCO:4747) Total Stockholders Equity : NT$1,727.0 Mil (As of Mar. 2025)

View and export this data going back to 2013. Start your Free Trial

What is Johnson Chemical Pharmaceutical Works Co Total Stockholders Equity?

Johnson Chemical Pharmaceutical Works Co's Total Stockholders Equity for the quarter that ended in Mar. 2025 was NT$1,727.0 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Johnson Chemical Pharmaceutical Works Co's Book Value per Share for the quarter that ended in Mar. 2025 was NT$38.44. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Johnson Chemical Pharmaceutical Works Co's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.09.

Johnson Chemical Pharmaceutical Works Co Total Stockholders Equity Historical Data

The historical data trend for Johnson Chemical Pharmaceutical Works Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Johnson Chemical Pharmaceutical Works Co Total Stockholders Equity Chart

Johnson Chemical Pharmaceutical Works Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

858.20

848.24

871.66

1,671.95

1,703.91

Johnson Chemical Pharmaceutical Works Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															1,704.27	1,662.00	1,683.70	1,703.91	1,726.97

Johnson Chemical Pharmaceutical Works Co (ROCO:4747) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Johnson Chemical Pharmaceutical Works Co's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(1726.967	-	0)	/	44.929
	=	38.44

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Johnson Chemical Pharmaceutical Works Co's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(60	+	90.695)	/	1726.967
	=	0.09

Johnson Chemical Pharmaceutical Works Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Johnson Chemical Pharmaceutical Works Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Johnson Chemical Pharmaceutical Works Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Johnson Chemical Pharmaceutical Works Co (ROCO:4747) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sanhe Road, No. 77 and No. 79, Section 4, Sanchong District, New Taipei, TWN, 241

Website

https://www.jcpjohnson.com.tw

Johnson Chemical Pharmaceutical Works Co is engaged in the manufacturing of pharmaceutical ingredients importing and selling pharmaceutical materials and products. It manufactures drugs in a variety of forms, including solid dosage forms, capsules (soft/hard), tablets (sugar/film-coated), powder and granule, as well as nasal sprays. It offers products in therapeutic areas including the central nervous system, respiratory, cardiovascular, gastrointestinal, and endocrine system, vitamins, anti-inflammatory, cough and cold, and pain relievers. Its organization revenue mainly comes from medical product sales.

Johnson Chemical Pharmaceutical Works Co Headlines

No Headlines